CN Stock MarketDetailed Quotes
300006 Chongqing Lummy Pharmaceutical
- 2.88
- +0.12+4.35%
Market Closed Apr 29 15:00 CST
3.04BMarket Cap-320000P/E (TTM)
2.89High2.77Low148.72KlotVolume2.78Open2.76Pre Close42.34MTurnover1.41%Turnover RatioLossP/E (Static)1.06BShares4.7552wk High1.46P/B3.04BFloat Cap2.0352wk Low3.31Limit Up1.06BShs Float21.82Historical High2.21Limit Down4.35%Amplitude2.03Historical Low--Dividend TTM2.85Avg Price62.54KlotAsk--Div YieldTTM100Lot Size86.67KlotBid
Chongqing Lummy Pharmaceutical Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 2.55%926.83M | -1.16%836.44M | 12.22%828.64M | 13.48%773.75M | 37.82%903.78M | 51.28%846.29M | 14.99%738.38M | -11.21%681.81M | -50.69%655.78M | 2.67%559.43M |
| Notes receivable and accounts receivable | 0.49%362.47M | -2.52%324.73M | -22.53%289.12M | -9.50%325.49M | -4.52%360.7M | -21.17%333.13M | -12.47%373.2M | -14.78%359.66M | -17.69%377.79M | -13.13%422.61M |
| -Notes receivable | -41.29%573.91K | -19.46%1.35M | 6.72%696.43K | 46.20%1.2M | --977.57K | 118.09%1.68M | -36.21%652.58K | -28.51%820.37K | ---- | -60.99%768.74K |
| -Accounts receivable | 0.60%361.89M | -2.44%323.38M | -22.58%288.43M | -9.63%324.29M | -4.78%359.72M | -21.43%331.45M | -12.41%372.55M | -14.75%358.84M | -17.47%377.79M | -12.93%421.84M |
| Other receivables (including interest and dividends) | -26.20%253.03M | -14.01%268.73M | -31.79%321.59M | -30.18%342.72M | -35.05%342.88M | -42.03%312.52M | 14.87%471.49M | 9.01%490.89M | 30.11%527.88M | 87.98%539.13M |
| -Accrued interest receivable | ---- | ---- | ---- | ---- | 581.54%1.2M | ---- | ---- | ---- | -72.97%175.77K | --650.34K |
| -Other receivable | ---- | ---- | ---- | -30.18%342.72M | ---- | -41.96%312.52M | ---- | 9.33%490.89M | ---- | 87.76%538.48M |
| Advance payment | 82.74%43.73M | -18.12%27.21M | 41.12%26.13M | 25.71%24.51M | 14.14%23.93M | 59.93%33.23M | -6.76%18.51M | -35.91%19.5M | -48.42%20.97M | -25.26%20.78M |
| Inventories | -6.81%179.65M | -15.52%171M | 1.30%173.84M | 1.33%195.75M | 11.82%192.77M | 28.28%202.4M | -22.48%171.61M | -17.30%193.19M | -24.70%172.4M | -46.82%157.77M |
| Receivable financing | -11.91%9.87M | -5.09%14.48M | 22.55%24.66M | -30.97%12.52M | -45.35%11.2M | -33.00%15.25M | -29.47%20.12M | -41.10%18.14M | -40.41%20.5M | -51.25%22.77M |
| Other current assets | -31.60%2.39M | 34.95%3.58M | 56.56%3.21M | 12.65%3.59M | -22.58%3.5M | -40.97%2.66M | -44.88%2.05M | -33.01%3.19M | 2.18%4.52M | -39.26%4.5M |
| Total current assets | -3.31%1.78B | -5.69%1.65B | -7.14%1.67B | -4.98%1.68B | 3.31%1.84B | 1.07%1.75B | 2.45%1.8B | -8.94%1.77B | -28.89%1.78B | 1.78%1.73B |
| Non Current assets | ||||||||||
| Other equity investment | -18.60%270.14M | -27.78%275.14M | -14.15%327.08M | -14.86%330.03M | -14.38%331.88M | -1.71%380.99M | -3.23%380.99M | 4.12%387.64M | 7.89%387.64M | 7.29%387.64M |
| Investment real estate | -22.75%1.04M | -29.25%1.03M | -25.13%1.16M | -23.64%1.26M | -22.32%1.35M | -21.14%1.45M | -20.08%1.55M | -19.12%1.64M | -18.25%1.74M | -73.23%1.84M |
| Long-term equity investment | 67.27%233.56M | 69.03%239.54M | 4.66%143.02M | 6.00%140.99M | 5.32%139.63M | 51.20%141.71M | 49.87%136.65M | 314.72%133.02M | 310.86%132.58M | -62.03%93.72M |
| Fixed assets | ---- | ---- | ---- | -13.12%304.99M | ---- | -13.38%323.97M | ---- | -7.69%351.06M | ---- | -15.60%374.02M |
| Fixed assets liquidation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.66M |
| Constru in process | ---- | ---- | ---- | -87.50%746.88K | ---- | -7.80%3.78M | ---- | -67.17%5.98M | ---- | -75.07%4.09M |
| Intangible assets | 5.13%196.26M | 2.82%189.3M | 35.41%177.14M | 63.79%184.82M | 62.96%186.68M | 58.23%184.11M | 10.74%130.82M | -6.21%112.84M | -6.20%114.55M | -25.29%116.36M |
| Development expenditure | -67.11%19.2M | -59.50%22.7M | 7.99%58.27M | -16.93%57.99M | -6.07%58.4M | -4.20%56.04M | -41.02%53.96M | -19.74%69.81M | -25.02%62.17M | -24.64%58.49M |
| Goodwill | 0.00%32.94M | 0.00%32.94M | 0.00%32.94M | 0.00%32.94M | 0.00%32.94M | 0.00%32.94M | 0.00%32.94M | 0.00%32.94M | 0.00%32.94M | -15.22%32.94M |
| Long deferred expense | -34.83%4.48M | -38.00%4.55M | 176.03%9.04M | 178.26%9.8M | 87.37%6.88M | 81.92%7.33M | 7.14%3.27M | 28.36%3.52M | 22.33%3.67M | -2.42%4.03M |
| Deferred tax assets | 16.99%133.17M | 13.53%132.35M | 9.14%123.04M | 7.89%123.77M | 8.97%113.83M | 11.43%116.58M | 22.28%112.74M | 26.31%114.73M | 16.73%104.46M | 12.84%104.62M |
| Usufruct assets | -45.58%6.04M | -36.41%7.74M | -34.28%8.33M | -29.54%9.77M | -21.04%11.09M | -15.35%12.17M | 54.90%12.68M | 54.65%13.87M | -22.58%14.05M | 65.94%14.38M |
| Other non current assets | -40.47%26.96M | 23.85%60.19M | 45.33%48.84M | 278.68%45.26M | 521.84%45.29M | 713.01%48.6M | 478.07%33.6M | 128.49%11.95M | 28.60%7.28M | -14.45%5.98M |
| Total non current assets | -3.74%1.2B | -4.96%1.24B | -1.44%1.22B | 0.27%1.24B | 1.35%1.25B | 9.16%1.31B | 1.29%1.24B | 7.43%1.24B | 5.89%1.23B | -17.81%1.2B |
| Total assets | -3.48%2.98B | -5.38%2.89B | -4.81%2.89B | -2.82%2.92B | 2.51%3.08B | 4.39%3.06B | 1.97%3.04B | -2.84%3.01B | -17.87%3.01B | -7.28%2.93B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 1.42%143M | -6.58%113.5M | -3.53%123M | -6.09%108M | 16.53%141M | -6.54%121.5M | 9.35%127.5M | -45.69%115M | -78.99%121M | -85.47%130M |
| Notes payable and accounts payable | -21.20%46.1M | -23.63%37.9M | 50.30%34.36M | 99.07%51.81M | 56.12%58.5M | 44.86%49.63M | -35.81%22.86M | -23.33%26.03M | -33.16%37.47M | -50.63%34.26M |
| -Notes payable | ---- | --3.21M | --8.87M | --5.66M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Accounts payable | -21.20%46.1M | -30.10%34.69M | 11.51%25.5M | 77.33%46.15M | 56.12%58.5M | 44.86%49.63M | -35.81%22.86M | -19.91%26.03M | -29.43%37.47M | -47.86%34.26M |
| Contract liabilities | -17.70%13.72M | -25.76%17.85M | 3.05%10.48M | 11.50%11.16M | 65.68%16.67M | 84.01%24.04M | -53.34%10.17M | -48.16%10.01M | -47.95%10.06M | -47.05%13.07M |
| Salaries payable | 81.20%20.74M | 2.63%29.97M | 1.26%12.57M | 14.22%14.52M | -9.28%11.45M | 2.68%29.2M | -0.43%12.41M | 6.61%12.72M | -7.75%12.62M | -17.92%28.44M |
| Taxs payable | -48.83%12.95M | -24.27%19.37M | -49.89%14.18M | -23.97%14.91M | 203.23%25.3M | -17.49%25.58M | 66.34%28.3M | 34.42%19.61M | -47.12%8.34M | 15.92%31M |
| Other payable (including interest and dividends) | -3.43%391.74M | -12.99%313.11M | -1.03%359.03M | 2.93%389.87M | 5.59%405.64M | -3.50%359.87M | 26.62%362.78M | 28.13%378.77M | 27.88%384.17M | -16.07%372.93M |
| -Interest payable | ---- | ---- | --11.26K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Dividend payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%5.76M | 0.00%5.76M |
| -Other payable | ---- | ---- | ---- | 2.93%389.87M | ---- | -1.99%359.87M | ---- | 30.68%378.77M | ---- | -16.28%367.17M |
| Non current liabilities due within one year | -38.27%56.22M | -67.96%28.26M | -62.59%35.77M | 29.01%72.5M | 55.55%91.07M | 59.17%88.2M | -12.39%95.62M | -47.71%56.2M | -69.12%58.54M | -73.16%55.41M |
| Other current liabilities | -22.79%1.7M | -25.96%2.31M | 31.54%1.38M | 35.32%1.44M | 118.78%2.2M | 83.66%3.12M | -55.61%1.05M | -51.18%1.07M | -58.02%1.01M | -45.54%1.7M |
| Total current liabilities | -8.73%686.16M | -19.81%562.27M | -10.58%590.77M | 7.24%664.23M | 18.73%751.83M | 5.15%701.14M | 9.84%660.7M | -11.11%619.4M | -46.03%633.22M | -60.87%666.8M |
| Current liabilities | ||||||||||
| Long term loan | -33.46%88.5M | -15.10%126.5M | -15.16%131.5M | -58.94%85M | -17.39%133M | --149M | --155M | --207M | --161M | ---- |
| Long term account payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | -81.99%24.65M |
| Estimate liabilities | --51.76M | --51.76M | --51.76M | --51.76M | ---- | ---- | ---- | ---- | ---- | ---- |
| Deferred tax liabilities | 364.35%19.4M | 331.13%19.26M | 160.43%4.17M | 150.86%4.08M | 152.78%4.18M | 166.19%4.47M | -6.73%1.6M | -6.17%1.63M | -6.08%1.65M | -65.10%1.68M |
| Long term deferred income | -29.13%5.95M | -29.32%6.39M | -34.52%6.09M | -30.68%7.32M | -27.17%8.39M | -26.25%9.04M | -12.37%9.3M | -7.79%10.56M | -8.58%11.52M | -8.73%12.26M |
| Lease liabilities | -47.32%2.52M | -61.51%2.53M | -47.68%3.53M | -48.58%4.09M | -38.88%4.79M | -29.03%6.57M | 37.89%6.74M | 31.75%7.96M | -39.84%7.83M | 51.39%9.25M |
| Total non current liabilities | 11.82%168.13M | 22.10%206.44M | 14.14%197.05M | -32.97%152.26M | -21.95%150.36M | 253.39%169.08M | 214.59%172.65M | 226.54%227.15M | 35.30%192.65M | -78.34%47.84M |
| Total liabilities | -5.31%854.3M | -11.66%768.71M | -5.46%787.82M | -3.55%816.49M | 9.24%902.18M | 21.77%870.22M | 26.96%833.34M | 10.46%846.55M | -37.23%825.86M | -62.87%714.65M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%1.06B | 0.00%1.06B | 0.00%1.06B | 0.00%1.06B | 0.00%1.06B | 0.00%1.06B | 0.00%1.06B | 0.00%1.06B | 0.00%1.06B | 30.00%1.06B |
| Capital reserve funds | 0.44%1.48B | 0.59%1.48B | 1.22%1.48B | 1.22%1.48B | 1.23%1.48B | 1.08%1.47B | -0.03%1.46B | -0.03%1.46B | -0.03%1.46B | 131.43%1.46B |
| Surplus reserve funds | 0.00%54.03M | 0.00%54.03M | 0.00%54.03M | 0.00%54.03M | 0.00%54.03M | 0.00%54.03M | 0.00%54.03M | 0.00%54.03M | 0.00%54.03M | 0.00%54.03M |
| Retained profit | -2.08%-473.51M | -1.89%-468.93M | -19.96%-514.51M | -11.41%-514.3M | -5.68%-463.87M | -11.56%-460.24M | -40.45%-428.9M | -57.57%-461.62M | -58.79%-438.95M | -26.80%-412.55M |
| Other composite income | ---43.77M | ---43.77M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Shareholders equity without minority interests | -2.21%2.08B | -2.06%2.08B | -3.17%2.07B | -1.66%2.07B | -0.33%2.12B | -1.48%2.12B | -5.48%2.14B | -7.43%2.11B | -7.11%2.13B | 84.10%2.16B |
| Minority interests | -21.39%46.12M | -31.40%41.51M | -50.59%31.94M | -38.15%31.89M | 11.71%58.67M | 8.49%60.52M | 9.97%64.64M | 2.25%51.56M | -3.51%52.52M | -7.48%55.78M |
| Total shareholder equity | -2.72%2.12B | -2.87%2.12B | -4.56%2.1B | -2.53%2.1B | -0.04%2.18B | -1.23%2.18B | -5.09%2.2B | -7.22%2.16B | -7.03%2.18B | 79.61%2.21B |
| Total liabilityies and equity | -3.48%2.98B | -5.38%2.89B | -4.81%2.89B | -2.82%2.92B | 2.51%3.08B | 4.39%3.06B | 1.97%3.04B | -2.84%3.01B | -17.87%3.01B | -7.28%2.93B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Sichuan Huaxin (Group) Accounting Firm (Special General Partnership) | -- | -- | -- | Sichuan Huaxin (Group) Accounting Firm (Special General Partnership) | -- | -- | -- | Sichuan Huaxin (Group) Accounting Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
%Chg